FDA Lifts Partial Clinical Hold on Heat’s Bladder Cancer Candidate

The FDA has lifted its partial clinical hold on Heat Biologics’ Phase 2 trial of its non-muscle invasive bladder cancer candidate HS-410.
Source: Clinical Trials Advisor